KIF20A and breast cancer: Experimental interventions aimed at inhibiting the endogenous KIF20A expression, either through the use of small interfering ribonucleic acids (siRNAs) or paprotrain (a selective KIF20A inhibitor), resulted in significant suppression of BC growth, through the arrest of the cell cycle at the G2/M phase, leading to subsequent mitotic cell death.